- RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
Kurt Sartorius et al, 2022, Frontiers in Oncology CrossRef - Maxizyme-mediated specific inhibition on mutant-type p53in vitro
Xin-Juan Kong, 2003, World Journal of Gastroenterology CrossRef - VEGF165antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma
Zhong-Ping Gu, 2002, World Journal of Gastroenterology CrossRef